…ry condition of the gut leading to increased risk of developing colorectal cancer (CRC). IBD-induced CRC, termed colitis-associated cancer (CAC),…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 364 of 2459…horts: those prescribed GLP-1 RAs (dulaglutide, semaglutide, or tirzepatide) and a control group with no exposure to GLP-1-based therapies.…
… (64.5%; rivaroxaban: 80%, VKAs: 20%) and beta-blockers (61.3%; propranolol: 52.6%, atenolol: 47.4%). Diuretics were added in 26.3% for asc…
… radical radiotherapy, with or without chemotherapy (RT±C), for oesophageal cancer, and may cause significant dysphagia requiring repeated endosco…
…uctal abnormalities (11/236), prior pancreatic surgery (7/236), pancreatic cancer (4/236), and autoimmune (AI) pancreatitis (3/236).Within this c…
…associated with upper GI cancer following a positive FIT and no colorectal cancer, inflammatory bowel disease or polyps on lower GI investigation…
…18.7%, mild ED 17.0%, moderate ED 6.1%, and severe ED 2.0%. For ulcerative colitis specifically, ED prevalence was 18.4%. Depression emerged as a …
…Introduction Elective discontinuation of Vedolizumab (VDZ) may be considered in patients achieving deep remission, b…
…2014: 55.6% [95% CI 54.8–56.4], 2022: 53.0% [95% CI 52.2–53.8]).Oesophageal cancer incidenceOesophageal national crude cancer incidence rates were…
… radiological follow-up was used as the reference standard. For pancreatic cancer, biopsy results were considered positive only when definitive m…
… oesophageal manometry (HRM) is the gold standard for assessing oesophageal motility disorders, but up to 10% of patients may be intolerant due to discomfort …
…ds for patients who underwent oesophageal physiology studies at St George’s Hospital between 2021 and 2025 was performed. Patients with outflow obst…